| Carcinoid syndrome with myasthenia gravis. An unusual and interesting case. | |
| | |
MedLine Citation:
|
PMID: 2871771 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The anaesthetic management of a patient suffering from carcinoid syndrome and myasthenia gravis is described including the successful treatment of a carcinoid attack with intravenous aprotonin. The differences between myasthenia gravis and the myasthenic (Eaton-Lambert) syndrome are considered and the rationale for the choice of vecuronium as the muscle relaxant is discussed. |
| | |
Authors:
|
S J Keens; M J Desmond; J E Utting |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Anaesthesia Volume: 41 ISSN: 0003-2409 ISO Abbreviation: Anaesthesia Publication Date: 1986 Apr |
Date Detail:
|
Created Date: 1986-05-28 Completed Date: 1986-05-28 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0370524 Medline TA: Anaesthesia Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 404-7 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Action Potentials
/
drug effects Aged Anesthesia, General* Blood Pressure / drug effects Humans Male Malignant Carcinoid Syndrome / complications*, surgery Myasthenia Gravis / complications* Neuromuscular Blocking Agents / pharmacology Pancuronium / analogs & derivatives, pharmacology Vecuronium Bromide |
| Chemical | |
Reg. No./Substance:
|
0/Neuromuscular Blocking Agents; 0/Pancuronium; 50700-72-6/Vecuronium Bromide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Vecuronium induced neuromuscular blockade. The effect of increasing dose on speed of onset.
Next Document: Isolation and characterization of milk protein nuclear RNAs in rat mammary gland.